Citation 61435

BIEBER,LW: DA SILVA FILHO,AA: CORREA LIMA,RMO: CHIAPPETA,AA: DO NASCIMENTO,SC: DE SOUZA,IA: DE MELLO,JF: VEITH,HJ:. (1986). ANTICANCER AND ANTIMICROBIAL GLYCOSIDES FROM IPOMOEA BAHIENSIS.. 25(5)

Citation Details

Title	ANTICANCER AND ANTIMICROBIAL GLYCOSIDES FROM IPOMOEA BAHIENSIS.
Authors	BIEBER,LW: DA SILVA FILHO,AA: CORREA LIMA,RMO: CHIAPPETA,AA: DO NASCIMENTO,SC: DE SOUZA,IA: DE MELLO,JF: VEITH,HJ:
Year	1986
Volume	25
Issue	5

Summary

Year: 1986

Journal: Unknown

Organisms and Their Experiments (1)

Ipomoea bahiensis (CONVOLVULACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
3	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
4	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
5	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
6	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
7	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
8	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
9	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
10	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
11	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
12	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
13	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
14	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
15	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
16	ANTIMYCOBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
17	ANTIMYCOBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
18	ANTIMYCOBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
19	ANTIYEAST ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
20	ANTIYEAST ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
21	ANTIYEAST ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
22	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	None
23	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
24	ANTIYEAST ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
25	ANTIYEAST ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
26	ANTIFUNGAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
27	ANTIFUNGAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
28	ANTIFUNGAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
29	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
30	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	WEAK ACTIVITY
31	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
32	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	WEAK ACTIVITY
33	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	None
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
35	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
38	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
39	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
40	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
41	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
42	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
43	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
44	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
45	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
46	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
47	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
48	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
49	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
50	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
51	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
52	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
53	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
54	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
55	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
56	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
57	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
58	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
59	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
60	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
61	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
62	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	INACTIVE
63	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	WEAK ACTIVITY
64	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
65	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
66	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	ACTIVE
67	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-A	WEAK ACTIVITY
68	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	None
69	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
70	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
71	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
72	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
73	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
74	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
75	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
76	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
77	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
78	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
79	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
80	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
81	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
82	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
83	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
84	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
85	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
86	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
87	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
88	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	None
89	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
90	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
91	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
92	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
93	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	INACTIVE
94	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
95	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
96	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
97	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
98	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
99	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
100	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
101	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
102	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
103	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	ACTIVE
104	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	WEAK ACTIVITY
105	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 1-B	WEAK ACTIVITY
106	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	None
107	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
108	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
109	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
110	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
111	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
112	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
113	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
114	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
115	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
116	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
117	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	None
118	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
119	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
120	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
121	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
122	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
123	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
124	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
125	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
126	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
127	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
128	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
129	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
130	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
131	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
132	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
133	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
134	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	ACTIVE
135	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	INACTIVE
136	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 2-A	WEAK ACTIVITY
137	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	None
138	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
139	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
140	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
141	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
142	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
143	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
144	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
145	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
146	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
147	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
148	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
149	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
150	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
151	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
152	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
153	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
154	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
155	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
156	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
157	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
158	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
159	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
160	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
161	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
162	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
163	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
164	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
165	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE
166	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	INACTIVE
167	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	IPOMOEA BAHIENSIS GLYCOSIDE 2-B	ACTIVE

Citation 61435

Citation Details

Summary

Organisms and Their Experiments (1)

Ipomoea bahiensis (CONVOLVULACEAE)

Show SPARQL Queries (1)

Query 1